Skip to main content
SupplementScience

Benefits of Beta-Sitosterol

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • BPH symptom relief — a landmark 1995 Lancet RCT (n=200) found 20mg TID beta-sitosterol significantly improved IPSS scores, urinary flow rate (+35%), and post-void residual volume vs placebo over 6 months
  • Cholesterol reduction — plant sterols including beta-sitosterol reduce LDL cholesterol by 6-15% by competing with dietary cholesterol for intestinal absorption, earning an FDA health claim
  • Prostate inflammation — in vitro and animal studies show beta-sitosterol inhibits 5-alpha-reductase and reduces prostaglandin synthesis in prostate tissue
  • Immune modulation — a 2003 study found beta-sitosterol enhanced natural killer cell activity and T-cell proliferation at physiological concentrations

What the Research Says

Beta-sitosterol has a solid evidence base for BPH. A 1999 Cochrane-style review by Wilt et al. analyzing 4 RCTs (n=519) concluded that beta-sitosterol significantly improves urologic symptoms and flow measures in men with BPH. The landmark Berges 1995 Lancet trial remains the most cited, showing a 7.4-point IPSS improvement vs 2.9 for placebo. For cholesterol, a 2008 meta-analysis confirmed plant sterols reduce LDL by 8-10% at 2g/day.

References

  1. (). Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. The Lancet. DOI
  2. (). Beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU International. DOI
  3. (). A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol for benign prostatic hyperplasia. British Journal of Urology. DOI
  4. (). Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food & Nutrition Research. DOI